A Network Toxicology Analysis of the Molecular Pathways and Novel Targets in Tcdd-Induced Cardiovascular Toxicity
dc.authorscopusid | 57201195704 | |
dc.contributor.author | Karakuş, F. | |
dc.date.accessioned | 2025-05-10T16:55:07Z | |
dc.date.available | 2025-05-10T16:55:07Z | |
dc.date.issued | 2024 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | Karakuş F., Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Van Yuzuncu Yil University, Van, Turkey | en_US |
dc.description.abstract | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), an environmental contaminant, disrupts multiple systems including endocrine, immun, nervous, reproductive, developmental, and cardiovascular. This study aimed to identify the molecular pathways and potential therapeutic targets for TCDD-induced cardiovascular toxicity using CTD, ShinyGO, STRING, GeneMANIA, ChEA3, MIENTURNET, and Cytoscape computational tools. The analysis identified the AGERAGE signaling pathway, blood circulation, and cytokine receptor binding as the top 3 among ten key molecular pathways, biological processes, and molecular functions associated with TCDD-induced cardiovascular toxicity. Additionally, ten hub proteins/genes were found to play a critical role, with NFKB1 being the most essential regulating transcription factor and hsa-miR-19a-3p and hsa-miR-125b-5p as the most crucial microRNAs. This study sheds light on the molecular mechanisms underlying TCDD-induced cardiovascular toxicity, revealing novel potential targets for therapeutic intervention. © 2024 Society of Pharmaceutical Sciences of Ankara (FABAD). All rights reserved. | en_US |
dc.identifier.doi | 10.55262/fabadeczacilik.1471982 | |
dc.identifier.endpage | 370 | en_US |
dc.identifier.issn | 1300-4182 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopus | 2-s2.0-85203398660 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 359 | en_US |
dc.identifier.uri | https://doi.org/10.55262/fabadeczacilik.1471982 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/3387 | |
dc.identifier.volume | 49 | en_US |
dc.identifier.wosquality | N/A | |
dc.institutionauthor | Karakuş, F. | |
dc.language.iso | en | en_US |
dc.publisher | Society of Pharmaceutical Sciences of Ankara (FABAD) | en_US |
dc.relation.ispartof | Fabad Journal of Pharmaceutical Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cardiovascular Toxicity | en_US |
dc.subject | Hsa-Mir-125B-5P | en_US |
dc.subject | Hsa-Mir-19A-3P | en_US |
dc.subject | Nfkb1 | en_US |
dc.subject | Tcdd. | en_US |
dc.title | A Network Toxicology Analysis of the Molecular Pathways and Novel Targets in Tcdd-Induced Cardiovascular Toxicity | en_US |
dc.type | Article | en_US |